Affiliation:
1. Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, Republic of Korea
2. Department of Dermatology, East Avenue Medical Center, Quezon City, Metro Manila, Philippines,
Abstract
Background
Several studies have reported that psoriasis has a positive correlation with type 2 diabetes mellitus (DM). Understanding the risk of psoriasis in diabetic patients is significant because it allows for early intervention and potential insights into the common pathways between the two conditions.
Objectives
We analysed the risk of psoriasis according to the estimated glomerular filtration rate (eGFR) and proteinuria level in DM patients using Korean population–based data.
Methods
This study was a retrospective cohort study using data collected from the country in the form of exploratory data analysis. A total of 927,234 participants diagnosed with DM were enrolled. Patients under the age of 20 with existing psoriasis or psoriasis developed within 1 year and missing data were excluded. The development of psoriasis was the primary outcome within a follow-up period of 7.83 ± 1.68 years.
Results
Of the 840,395 final participants, 28,010 (3.33%) patients developed psoriasis. In multivariate-adjusted Cox proportional hazards regression models, the DM patients with eGFR < 30 had a higher risk of psoriasis after adjustment (eGFR 60–90, hazard ratio [HR] 1 (Ref.); eGFR < 30, HR 1.173, 95% CI 1.089–1.264). In addition, there was an increased psoriatic risk of patients with DM and proteinuria after adjustment (negative, HR 1 (Ref.); 2+, HR 1.164, 95% CI 1.080–1.254; 3+, HR 1.433, 95% CI 1.273–1.613; 4+, HR 1.508, 95% CI 1.177–1.931).
Limitations
The severity of psoriasis was not measured since the occurrence of psoriasis was the outcome. Details of oral hypoglycaemic agents such as type and dose were not investigated.
Conclusion
This study showed that a decrease in eGFR and aggravation of proteinuria increase the risk of psoriasis in diabetic patients. Therefore, by using eGFR and proteinuria as predictive risk factors of psoriasis in DM patients, early and proactive treatment may play a vital role in managing diabetic patients.
Reference26 articles.
1. All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis;Dhana;J Am Acad Dermatol,2019
2. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017;Mehrmal;J Am Acad Dermatol,2021
3. Psoriasis and comorbid diseases: Epidemiology;Takeshita;J Am Acad Dermatol,2017
4. Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis;Armstrong;JAMA Dermatol,2013
5. Psoriasis, psoriatic arthritis, and type 2 diabetes mellitus: A systematic review and meta-analysis;Coto-Segura;Br J Dermatol,2013